27 - 29 May, 2026
Congress CenterBasel Switzerland Annette Vogl, PhDVP, Biology and Translational Research at TubulisSpeaker
Profile
With Tubulis since 2020; heading the Biology department; current position at Tubulis VP Biology and Translational Research. Tubulis is a Munich based biotech company developing next-generation ADCs with novel linker chemistry. Before joining Tubulis I worked at Genentech from 2015-2020, focusing on protein degradation and neurodegenerative diseases. Holding a PhD in Neurobiology and Neurosciences from the Max Planck Institute of Psychiatry and the Technical University of Munich.
Agenda Sessions
The Tubutecan ADC Platform – Highlighting the Development of TUB-040, A Next-generation NaPi2b-targeting ADC with Stably Linked Exatecan
, 14:15View Session